• 7/05 – 6/08    Fellowhip in Gastroenterology, Beth Israel Deaconess Medical Center / Harvard Medical School. Boston, MA.
• 7/04 – 6/05    Fellowship in Hepatology, Beth Israel Deaconess Medical Center / Harvard Medical School. Boston, MA.
• 7/03 – 6/04    Fellowship in Clinical Nutrition, Dept of Gastroenterology, Hepatology,& Nutrition, Cleveland Clinic Foundation. Cleveland, OH. 
• 7/00 – 6/03     Residency in Internal Medicine at Unity Health, an affiliate of University of Rochester. Rochester, NY.
• 9/92 – 6/98     Medical school: Allama Iqbal Medical College Lahore, Pakistan.

BOARD CERTIFICATION

•    2008-2018                          Board certified in Gastroenterology       
•   2003-2013                           Board certified in Internal Medicine

• Hepatology and Nutrition

• Ahmad S, Haider N, Khokhar AS et al. Evaluation of AST/ALT ratio in patients with liver disease and to evaluate its significance as a predictor of cirrhosis in Pakistani population. Pak J Med Sci Oct-Dec 2001 Vol.17 No.4 225-228
• Khokhar AS, Disalle M, Dytoc J. Esophageal Actinomycosis associated with a stricture. Poster presented at the ACP-ASIM New York Upstate Scientific Meeting in October 2002 
• Khokhar AS, Seidner DL. The Pathophysiology of Pancreatitis. Nutrition in Clinical Practice 19:5-15, February 2004. 
• Book chapter on “Metabolic Bone Disease in Gastrointestinal Illnesses in the book “Clinical Nutrition for Gastroenterologists” by Alan Buchman – Published June 2006 
• A.Khokhar, R.Farnan, C.MacFarlane, B.Bacon, J.McHutchison, N.Afdhal. Liver Stiffness and Biomarkers: Correlation with extent of fibrosis, Portal hypertension and Hepatic synthetic function. Hepatology 2005. Vol. 42, No.4, Suppl 1.Abstract 601. Poster presented at AASLD annual meeting 2005 in San Francisco. 
• Liver Stiffness and Biomarkers: Correlation with Extent of Fibrosis, Portal Hypertension and Hepatic Synthetic Function. Oral presentation at the Young Investigators forum / Controversies in Transplant, Denver, CO. March 2nd, 2006
• Popov Y , Patsenker Y, Khokhar A, Niedobitek E, Schuppan D. Cirrhosis reversal by antifibrotic combination therapy. Potentiation of the antifibrotoc effect of Mycophenolate Mofetil by Pioglitazone and Halofuginone. Abstract / Poster Presented at EASL 2006 in Vienna Austria. 
• Popov Y, Khokhar A, Patsenker E, Niedobitek E, Schuppan D. Potentiation of the Antifibrotic Effect of Mycophenolate By Pioglitazone and Halfuginone in a Rat Model of Cirrhosis Reversal. Gastroenterology 2006. Volume 130, No.4 , Suppl 2. Abstract #226. Presented at DDW 2006 in LA 
• Khokhar A, Byrnes V, Afdhal N. Future HCV therapies. Current hepatitis reports. Volume 5, Number 3: August 2006 • Hepatitis C: Current and Future Therapies • pp. 121-128 
• Popov Y, Millonig G, Khokhar A. The Antifibrotic Effect of Mycophenolate Mofetil is Lost at Clinically Relevant Dose, Following a Biphasic Dose-Dependent Pattern in Liver Fibrosis. Poster presented at EASL 2007